Research Peptides · Cat. 035-36A
INSL7 / Relaxin 3 (Human)
Supplied as 100 µg per unit. Purity ≥ 95%. Molecular weight 5500.49. Species: Human. Technical values shown are imported catalog fields and should be confirmed against current documentation. Laboratory research use only.
Specifications
| Catalog number | 035-36A |
|---|---|
| Product type | Research Peptides |
| Peptide family | Insulin-Like Peptide 7 / Relaxin-3 (INSL7) |
| Species | Human |
| Unit size | 100 µg |
| Molecular weight | 5500.49 Da |
| Purity | ≥ 95% |
| Validation | Exhibits correct molecular weight |
| Appearance | White powder |
| Contents | Each vial contains 100 µg of NET peptide. |
| B-Chain | Arg-Ala-Ala-Pro-Tyr-Gly-Val-Arg-Leu-Cys-Gly-Arg-Glu-Phe-Ile-Arg-Ala-Val-Ile-Phe-Thr-Cys-Gly-Gly-Ser-Arg-Trp |
| Solubility | Soluble in water |
| Disulfide Bridge | Disulfide bridge(s): CysA10-CysA15, CysA11-CysB10, CysA24-CysB22 Relaxin-3 stimulates the hypothalamic-pituitary-gonadal axis. Mcgowan BM, Stanley SA, Donovan J, et al. Am J Physiol Endocrinol Metab. 2008;295(2):E278-86. The insulin-like growth factor type 1 and insulin-like growth factor type 2/mannose-6-phosphate receptors independently regulate ERK1/2 activity in HEK293 cells. El-shewy HM, Lee MH, Obeid LM, Jaffa AA, Luttrell LM. J Biol Chem. 2007;282(36):26150-7. Hypothalamic mapping of orexigenic action and Fos-like immunoreactivity following relaxin-3 administration in male Wistar rats. Mcgowan BM, Stanley SA, White NE, et al. Am J Physiol Endocrinol Metab. 2007;292(3):E913-9. Relaxin receptors in hepatic stellate cells and cirrhotic liver. Bennett RG, Dalton SR, Mahan KJ, Gentry-nielsen MJ, Hamel FG, Tuma DJ. Biochem Pharmacol. 2007;73(7):1033-40. Chronic intracerebroventricular administration of relaxin-3 increases body weight in rats. Hida T, Takahashi E, Shikata K, et al. J Recept Signal Transduct Res. 2006;26(3):147-58. Relaxin receptor expression in hepatic stellate cells and in cirrhotic rat liver tissue. Bennett RG, Mahan KJ, Gentry-nielsen MJ, Tuma DJ. Ann N Y Acad Sci. 2005;1041:185-9. |
| Research topics | Cardiovascular Research, Obesity & Appetite |
| Intended use | In vitro laboratory research only — not for human or veterinary use, diagnostic or therapeutic purposes |
Sequence
Asp-Val-Leu-Ala-Gly-Leu-Ser-Ser-Ser-Cys-Cys-Lys-Trp-Gly-Cys-Ser-Lys-Ser-Glu-Ile-Ser-Ser-Leu-Cys
Storage & handling
Up to 6 months in lyophilized form at 0-5°C. For best results, rehydrate just before use. After rehydration, keep solution at +4°C for up to 5 days or freeze at -20°C for up to 3 months. Aliquot before freezing to avoid repeated freeze-thaw cycles.
Confirm handling and preparation requirements against current product documentation and the requirements of your laboratory protocol.
Frequently asked
What is INSL7 / Relaxin 3 (Human)?
What purity is listed for 035-36A?
How should INSL7 / Relaxin 3 (Human) be stored?
What is the sequence of INSL7 / Relaxin 3 (Human)?
What is the intended use of 035-36A?
This page reproduces an imported research-catalog record. Verify identity, specifications, documentation and suitability before purchase. The item is offered only for laboratory research and is not represented for human or veterinary use.